HealthLeaders Media February 22, 2024
John Commins

A bipartisan coalition of 39 AGs wants Congress and the FTC ‘to ensure fulsome regulation of PBMs nationwide.’

KEY TAKEAWAYS

– The AGs claim that a ‘small number of PBMs hold significant market power and are reaping abundant profits at the expense of the patients, employers, and government payors the PBMs are supposed to help.’

– The AGs are urgin Congress to pass three bills that would address alleged PBM abuses at the federal level and back states’ efforts to regulate the drug purchas middlemen.

– PBMs say they’re being unfairly scapegoated for high drug costs that are set by drugmakers using anti-competitive tactics such as extending drug patent monopolies.

The National Association of Attorneys General is urging Congress...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, Govt Agencies, Pharma, Pharma / Biotech, Regulations, States
Mark Cuban: A Master Disrupter for American Healthcare
Despite Trump’s Tough Talk On PBMs, GOP House Lets Them Off The Hook
How has U.S. Spending on Health Care Changed Over Time?
Merck enters $2B licensing deal for weight loss drug
What are pharmacy benefit managers? A health economist explains how lack of competition drives up drug prices

Share This Article